Purpose

The goal of this study is to learn more about the brain pathways and activity involved in creating Visual Snow Syndrome (VSS). The main questions it aims to answer are: - Does VSS arise from spontaneous activity in brain pathways? - Where in the brain does the activity contributing to VSS arise? - How does brain activity contribute to VSS? Participants will: 1. Undergo assessments and questionnaires to understand visual and mental symptoms, cognitive, and sensory function. 2. Make visual judgements based on images presented to them both inside and outside a magnetic resonance imaging (MRI) machine. 3. Undergo scanning of their brain while inside of an MRI machine.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 60 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

for People with Visual Snow Syndrome: - Between the ages of 18 and 60 years old - Normal (20/25 or better in each eye) or corrected-to-normal vision (MR-compatible glasses will be provided as needed) - Ability to comply with study instructions - Individuals who have a current diagnosis of VSS from a neuro-ophthalmologist or meet diagnostic criteria of VSS (experience of dynamic dots across the visual field persisting longer than 3 months and at least 2 of the following additional visual symptoms: palinopsia, entoptic phenomena, trails behind moving objects, photophobia, or nyctalopia) - Individuals living in Minnesota within 2 hours of the study site Inclusion Criteria for Non-snow Controls: - Between the ages of 18 and 60 years old - Normal (20/25 or better in each eye) or corrected-to-normal vision (MR-compatible glasses will be provided as needed) - Ability to comply with study instructions - Individuals living in Minnesota within 2 hours of the study site

Exclusion Criteria

for People with Visual Snow Syndrome: - Not being fluent in English or another language for which interpretation/translation services are available - A diagnosed or self-reported intellectual disability - Current substance dependence (besides nicotine), or drug dependence with tolerance or withdrawal within past 12 months - Hallucinogenic substance use within the past 12 months or hallucinogenic substance use within 12 months prior to onset of VSS symptoms - Severe central nervous system disease - Head injury with skull fracture or loss of consciousness for more than thirty minutes - Presence of a physical problem that would render study measures difficult or impossible to administer or interpret (e.g., visual field loss) - Age less than 18 years or greater than 60 years - MRI exclusions (for MR visits only): - Metal in the body that cannot be approved by the CMRR safety committee - Pregnancy - Conditions that affect neuro-hemodynamic coupling - Claustrophobia - Inability to lie still for at least an hour - Weight in excess of 440 lbs - CT scan exclusion only: Research-related radiation exposure within the last 12 months - Any vision anomaly aside from VS or refractive error (e.g., strabismus/ crossed eyes, lazy eyes, color blindness) - Current psychotic episode Exclusion Criteria for Non-snow Controls: - Not being fluent in English or another language for which interpretation/translation services are available - A diagnosed or self-reported intellectual disability - Current substance dependence (besides nicotine), or drug dependence with tolerance or withdrawal within past 12 months - Hallucinogenic substance use within the past 12 months - Severe central nervous system disease - Head injury with skull fracture or loss of consciousness for more than thirty minutes - Presence of a physical problem that would render study measures difficult or impossible to administer or interpret (e.g., visual field loss) - Age less than 18 years or greater than 60 years - MRI exclusions (for MR visits only): - Metal in the body that cannot be approved by the CMRR safety committee - Pregnancy - Conditions that affect neuro-hemodynamic coupling - Claustrophobia - Inability to lie still for at least an hour - Weight in excess of 440 lbs - CT scan exclusion only: Research-related radiation exposure within the last 12 months - Any vision anomaly or refractive error (e.g. strabismus/ crossed eyes, lazy eyes, color blind) - A personal history of VSS symptoms or a diagnosis with VSS - Current psychotic episode

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Non-Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
People with Visual Snow Syndrome
  • Behavioral: Visual Adaptation
    Presentation of visual stimuli to quantify the appearance of visual snow or its effects in the visual system of the brain.
  • Behavioral: Assessments and Questionnaires
    Administration of clinical assessments and questionnaires to gather information about visual and mental symptoms, cognitive, and sensory function.
  • Device: Functional Magnetic Resonance Imaging (fMRI)
    7 tesla fMRI data will be acquired during visual paradigms designed to measure neural responses with and without adaptation.
  • Device: Magnetic Resonance Imaging (MRS)
    7 tesla MRS data will be acquired to quantify the concentrations of different brain chemicals in brain regions including visual cortex.
Placebo Comparator
Non-snow Controls
  • Behavioral: Visual Adaptation
    Presentation of visual stimuli to quantify the appearance of visual snow or its effects in the visual system of the brain.
  • Behavioral: Assessments and Questionnaires
    Administration of clinical assessments and questionnaires to gather information about visual and mental symptoms, cognitive, and sensory function.
  • Device: Functional Magnetic Resonance Imaging (fMRI)
    7 tesla fMRI data will be acquired during visual paradigms designed to measure neural responses with and without adaptation.
  • Device: Magnetic Resonance Imaging (MRS)
    7 tesla MRS data will be acquired to quantify the concentrations of different brain chemicals in brain regions including visual cortex.

Recruiting Locations

University of Minnesota
Minneapolis, Minnesota 55455
Contact:
Michael-Paul Schallmo, Ph.D., Assistant Professor
612-273-9130
schallmolab@umn.edu

More Details

NCT ID
NCT06961864
Status
Recruiting
Sponsor
University of Minnesota

Study Contact

Michael-Paul Schallmo, Ph.D.
(612) 273-9130
schallmolab@umn.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.